Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.19.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Mar. 30, 2019
Mar. 31, 2018
Mar. 30, 2019
Mar. 31, 2018
Income Statement [Abstract]        
Net sales $ 102,838 $ 100,004 $ 204,513 $ 190,346
Cost of goods sold 83,930 77,769 167,036 151,741
Gross profit 18,908 22,235 37,477 38,605
Selling, general and administrative expenses 17,056 16,737 33,841 31,717
Other (income) expense, net (843) (116) 902 (464)
Operating income 2,695 5,614 2,734 7,352
Interest expense, net 1,985 1,350 3,750 2,685
Income (loss) before (benefit from) provision for income taxes 710 4,264 (1,016) 4,667
(Benefit from) provision for income taxes (115) 632 (614) 10,988
Consolidated net income (loss) 825 3,632 (402) (6,321)
Less: Net loss attributable to non-controlling interest (117) 0 (193) 0
Net income (loss) attributable to shareholders $ 942 $ 3,632 $ (209) $ (6,321)
Basic income (loss) per share (in dollars per share) $ 0.14 $ 0.50 $ (0.03) $ (0.87)
Diluted income (loss) per share (in dollars per share) $ 0.13 $ 0.48 $ (0.03) $ (0.87)
Weighted average number of shares outstanding (in shares) 6,943 7,195 6,933 7,231
Dilutive effect of stock awards (in shares) 160 301 0 0
Weighted average number of shares assuming dilution (in shares) 7,103 7,496 6,933 7,231